Literature DB >> 17967895

Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels.

Renaud Lefloch1, Jacques Pouysségur, Philippe Lenormand.   

Abstract

The proteins ERK1 and ERK2 are highly similar, are ubiquitously expressed, and share activators and substrates; however, erk2 gene invalidation is lethal in mice, while erk1 inactivation is not. We ablated ERK1 and/or ERK2 by RNA interference and explored their relative roles in cell proliferation and immediate-early gene (IEG) expression. Reducing expression of either ERK1 or ERK2 lowered IEG induction by serum; however, silencing of only ERK2 slowed down cell proliferation. When both isoforms were silenced simultaneously, compensating activation of the residual pool of ERK1/2 masked a more deleterious effect on cell proliferation. It was only when ERK2 activation was clamped at a limiting level that we demonstrated the positive contribution of ERK1 to cell proliferation. We then established that ERK isoforms are activated indiscriminately and that their expression ratio correlated exactly with their activation ratio. Furthermore, we determined for the first time that ERK1 and ERK2 kinase activities are indistinguishable in vitro and that erk gene dosage is essential for survival of mice. We propose that the expression levels of ERK1 and ERK2 drive their apparent biological differences. Indeed, ERK1 is dispensable in some vertebrates, since it is absent from chicken and frog genomes despite being present in all mammals and fishes sequenced so far.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17967895      PMCID: PMC2223286          DOI: 10.1128/MCB.00800-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  A conserved docking motif in MAP kinases common to substrates, activators and regulators.

Authors:  T Tanoue; M Adachi; T Moriguchi; E Nishida
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

2.  ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis.

Authors:  Tanya Nekrasova; Carey Shive; Yuehua Gao; Kazuyuki Kawamura; Rocio Guardia; Gary Landreth; Thomas G Forsthuber
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

3.  Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice.

Authors:  G Pagès; S Guérin; D Grall; F Bonino; A Smith; F Anjuere; P Auberger; J Pouysségur
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

4.  Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists.

Authors:  Tomas Vomastek; Hans-Joerg Schaeffer; Adel Tarcsafalvi; Mark E Smolkin; Eric A Bissonette; Michael J Weber
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

5.  Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.

Authors:  Kanaga Sabapathy; Konrad Hochedlinger; Shin Yuen Nam; Anton Bauer; Michael Karin; Erwin F Wagner
Journal:  Mol Cell       Date:  2004-09-10       Impact factor: 17.970

6.  The MAP kinase pathway is required for entry into mitosis and cell survival.

Authors:  Xiaoqi Liu; Shi Yan; Tianhua Zhou; Yasuhiko Terada; Raymond L Erikson
Journal:  Oncogene       Date:  2004-01-22       Impact factor: 9.867

7.  Major events in the genome evolution of vertebrates: paranome age and size differ considerably between ray-finned fishes and land vertebrates.

Authors:  Klaas Vandepoele; Wouter De Vos; John S Taylor; Axel Meyer; Yves Van de Peer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-02       Impact factor: 11.205

8.  p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis.

Authors:  Christine Bourcier; Arnaud Jacquel; Jochen Hess; Isabelle Peyrottes; Peter Angel; Paul Hofman; Patrick Auberger; Jacques Pouysségur; Gilles Pagès
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

9.  Essential role for ERK2 mitogen-activated protein kinase in placental development.

Authors:  Naoya Hatano; Yoshiko Mori; Masatsugu Oh-hora; Atsushi Kosugi; Takahiko Fujikawa; Naoya Nakai; Hitoshi Niwa; Jun-ichi Miyazaki; Toshiyuki Hamaoka; Masato Ogata
Journal:  Genes Cells       Date:  2003-11       Impact factor: 1.891

10.  Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism.

Authors:  M Adachi; M Fukuda; E Nishida
Journal:  J Cell Biol       Date:  2000-03-06       Impact factor: 10.539

View more
  79 in total

1.  Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1.

Authors:  Gregory P Botta; Mauricio J Reginato; Maximilian Reichert; Anil K Rustgi; Peter I Lelkes
Journal:  Mol Cancer Res       Date:  2011-12-08       Impact factor: 5.852

2.  Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia.

Authors:  Anatoliy I Masyuk; Bing Q Huang; Christopher J Ward; Sergio A Gradilone; Jesus M Banales; Tatyana V Masyuk; Brynn Radtke; Patrick L Splinter; Nicholas F LaRusso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-15       Impact factor: 4.052

3.  In-situ generation of differential sensors that fingerprint kinases and the cellular response to their expression.

Authors:  Diana Zamora-Olivares; Tamer S Kaoud; Kevin N Dalby; Eric V Anslyn
Journal:  J Am Chem Soc       Date:  2013-09-18       Impact factor: 15.419

Review 4.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

5.  Deletion of ERK2 mitogen-activated protein kinase identifies its key roles in cortical neurogenesis and cognitive function.

Authors:  Ivy S Samuels; J Colleen Karlo; Alicia N Faruzzi; Kathryn Pickering; Karl Herrup; J David Sweatt; Sulagna C Saitta; Gary E Landreth
Journal:  J Neurosci       Date:  2008-07-02       Impact factor: 6.167

6.  ERK nuclear translocation is dimerization-independent but controlled by the rate of phosphorylation.

Authors:  Diane S Lidke; Fang Huang; Janine N Post; Bernd Rieger; Julie Wilsbacher; James L Thomas; Jacques Pouysségur; Thomas M Jovin; Philippe Lenormand
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

7.  Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development.

Authors:  Jason Newbern; Jian Zhong; Rasika S Wickramasinghe; Xiaoyan Li; Yaohong Wu; Ivy Samuels; Natalie Cherosky; J Colleen Karlo; Brianne O'Loughlin; Jamie Wikenheiser; Madhusudhana Gargesha; Yong Qiu Doughman; Jean Charron; David D Ginty; Michiko Watanabe; Sulagna C Saitta; William D Snider; Gary E Landreth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

Review 8.  The Role of PI3K/Akt and ERK in Neurodegenerative Disorders.

Authors:  Sachchida Nand Rai; Hagera Dilnashin; Hareram Birla; Saumitra Sen Singh; Walia Zahra; Aaina Singh Rathore; Brijesh Kumar Singh; Surya Pratap Singh
Journal:  Neurotox Res       Date:  2019-02-01       Impact factor: 3.911

9.  Dusp6 is a genetic modifier of growth through enhanced ERK activity.

Authors:  Andy H Vo; Kayleigh A Swaggart; Anna Woo; Quan Q Gao; Alexis R Demonbreun; Katherine S Fallon; Mattia Quattrocelli; Michele Hadhazy; Patrick G T Page; Zugen Chen; Ascia Eskin; Kevin Squire; Stanley F Nelson; Elizabeth M McNally
Journal:  Hum Mol Genet       Date:  2019-01-15       Impact factor: 6.150

Review 10.  From basic research to clinical development of MEK1/2 inhibitors for cancer therapy.

Authors:  Christophe Frémin; Sylvain Meloche
Journal:  J Hematol Oncol       Date:  2010-02-11       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.